Atherectomy Systems Market Outlook

The global atherectomy systems market is projected to reach approximately USD 1.45 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2035. This growth can be largely attributed to the rising prevalence of cardiovascular diseases, which necessitate advanced interventional procedures. The increasing adoption of minimally invasive surgical techniques and the growing geriatric population further drive market demand. Additionally, technological advancements in atherectomy devices are enhancing their efficacy and safety, leading to improved patient outcomes and higher acceptance rates among healthcare professionals. The rising expenditure on healthcare, coupled with the growing number of hospitals and surgical centers equipped with advanced medical technologies, is poised to contribute significantly to the market expansion during the forecast period.

Growth Factor of the Market

The atherectomy systems market is experiencing robust growth propelled by several factors. Firstly, the increasing incidence of atherosclerosis and peripheral and coronary artery diseases is a primary driver, as these conditions require effective treatment solutions. Moreover, advancements in atherectomy technology, such as the development of more efficient, safer, and user-friendly devices, are enhancing procedural outcomes and patient satisfaction. The rise in healthcare infrastructure and investments, particularly in emerging markets, is also significant, as it leads to greater accessibility and availability of advanced medical devices. Furthermore, the trend toward outpatient procedures is driving demand for atherectomy systems, as hospitals and surgical centers strive to reduce costs while improving patient turnover. Lastly, heightened awareness and education about cardiovascular health are encouraging individuals to seek medical intervention sooner, further boosting market growth.

Key Highlights of the Market

• The atherectomy systems market is expected to grow at a CAGR of 6.2% from 2025 to 2035.
• Technological advancements are driving the development of innovative and more effective atherectomy devices.
• Increasing prevalence of cardiovascular diseases is leading to higher demand for atherectomy systems.
• The growing geriatric population is contributing to the market's expansion as they are more susceptible to cardiovascular conditions.
• Emerging markets are seeing significant investments in healthcare infrastructure, facilitating the growth of the atherectomy systems market.

By Product Type

Directional Atherectomy Systems:

Directional atherectomy systems are designed to precisely remove plaque from arterial walls while preserving healthy vascular tissue. These systems employ a cutting mechanism that allows surgeons to target specific lesions, making them particularly effective for treating peripheral artery disease. The growing prevalence of this condition, along with the increasing number of minimally invasive procedures, is driving the demand for directional atherectomy systems. Their ability to facilitate faster recovery times and reduce overall procedural risks further enhances their appeal among healthcare providers and patients alike. Additionally, ongoing innovations in device design and functionality are expected to expand the applications and effectiveness of directional atherectomy systems in various clinical settings.

Rotational Atherectomy Systems:

Rotational atherectomy systems utilize a rotating diamond-coated burr to ablate and remove plaque from the artery, thereby restoring blood flow. These systems are particularly beneficial for treating heavily calcified lesions, which are often challenging to manage with conventional angioplasty alone. The demand for rotational atherectomy systems is on the rise, driven by an increasing number of complex cardiovascular interventions and the growing need for effective treatment options for patients with advanced atherosclerotic disease. The introduction of new, improved designs that enhance maneuverability and reduce procedural complications is expected to further fuel the growth of this segment, making it a vital component of the overall atherectomy systems market.

Orbital Atherectomy Systems:

Orbital atherectomy systems offer a unique approach to plaque removal through the use of an orbital motion that allows for the efficient treatment of atherosclerotic lesions. This method is particularly effective for patients with calcium-rich plaques, which can often complicate traditional intervention strategies. The market for orbital atherectomy systems is expanding, driven by increasing clinical evidence supporting their efficacy and safety profile. As more healthcare professionals recognize the benefits of orbital atherectomy in improving patient outcomes, the adoption of these systems is expected to rise. Furthermore, ongoing research and development efforts aimed at enhancing the technology will continue to attract interest in this segment.

Laser Atherectomy Systems:

Laser atherectomy systems utilize focused laser energy to vaporize plaque and thrombus within the artery, providing a minimally invasive solution for treating various cardiovascular conditions. The growing awareness of the advantages of laser technology in reducing the risk of vascular injury and improving recovery times is driving market growth for laser atherectomy systems. As the global burden of cardiovascular diseases continues to rise, the demand for effective and less invasive treatment options is expected to increase. Furthermore, advancements in laser technology, such as the development of more precise and efficient systems, are set to enhance the effectiveness of laser atherectomy, thus expanding its market presence.

Mechanical Atherectomy Systems:

Mechanical atherectomy systems employ a mechanical mechanism for the removal of arterial plaque, allowing for effective treatment of both peripheral and coronary artery diseases. The increasing prevalence of these diseases, combined with the growing preference for minimally invasive procedures, is bolstering the demand for mechanical atherectomy systems. These devices offer the advantage of being versatile, allowing for use in various clinical situations, including challenging lesions. As the healthcare sector progresses towards adopting technologies that enhance patient safety and procedural efficiency, mechanical atherectomy systems are likely to gain further traction in the competitive landscape.

By Application

Peripheral Artery Disease:

Peripheral artery disease (PAD) is a common circulatory problem that affects the arteries leading to the limbs, primarily caused by atherosclerosis. The atherectomy systems market is significantly driven by the need for effective treatment solutions for PAD, as traditional methods may not always yield satisfactory results. Atherectomy procedures allow for targeted removal of plaque in the peripheral arteries, improving blood flow and alleviating symptoms such as pain and discomfort during physical activities. With the increasing incidence of PAD, the market for atherectomy systems aimed at treating this condition is expected to witness substantial growth as healthcare providers seek better outcomes for their patients.

Coronary Artery Disease:

Coronary artery disease (CAD) is characterized by the buildup of plaque in the coronary arteries, leading to reduced blood flow to the heart. The demand for atherectomy systems in treating CAD is growing, as these devices offer a minimally invasive approach to restore normal blood flow. Atherectomy can be particularly effective in cases of complex lesions that may not respond well to standard balloon angioplasty or stenting. The increasing prevalence of CAD, driven by lifestyle factors such as obesity and sedentary behavior, is propelling the growth of atherectomy systems designed for coronary interventions. Moreover, advancements in technology are enabling more efficient and safer procedures, further enhancing the market attractiveness for this application segment.

By End User

Hospitals:

Hospitals are the primary end users of atherectomy systems, as they provide a wide range of cardiovascular interventions, including complex surgeries that necessitate the use of these devices. The increasing number of hospital admissions due to cardiovascular diseases has led to a higher demand for advanced interventional tools, including atherectomy systems. Moreover, hospitals are integrating new technologies to improve patient outcomes while reducing recovery times, driving the adoption of atherectomy procedures. As healthcare facilities continue to invest in cutting-edge medical technologies to enhance their service offerings, the market for atherectomy systems in hospitals is expected to expand significantly over the coming years.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming increasingly important as end users of atherectomy systems, primarily due to the growing trend towards outpatient procedures. ASCs offer patients the benefit of undergoing less invasive surgeries in a cost-effective environment, which is appealing in an era of rising healthcare costs. The adoption of atherectomy systems in ASCs is driven by the demand for efficient and rapid interventions that can help improve patient turnover. As more patients seek minimally invasive treatment options that allow for quicker recovery and lower hospitalization rates, the role of ASCs in the atherectomy systems market is set to grow significantly.

Specialty Clinics:

Specialty clinics, particularly those focusing on cardiovascular health, are increasingly utilizing atherectomy systems to provide targeted treatments for conditions such as PAD and CAD. These clinics benefit from specialized expertise and advanced technology, allowing them to offer precise and effective interventions tailored to individual patient needs. The growing number of specialty clinics dedicated to cardiovascular care is driving demand for atherectomy systems, as they seek to enhance their treatment capabilities and improve patient outcomes. Additionally, the emphasis on personalized medicine and the rising awareness of cardiovascular diseases among the population are expected to further bolster the market for atherectomy systems in specialty clinics.

By Sales Channel

Direct Sales:

Direct sales represent a significant segment in the distribution of atherectomy systems, as manufacturers often prefer to engage directly with healthcare facilities to ensure optimal product understanding and support. By building direct relationships with hospitals and surgical centers, manufacturers can provide tailored solutions that meet the specific needs of their clients. This approach allows for better training, support, and maintenance, which can lead to improved patient outcomes. The trend toward direct sales is likely to continue, as companies recognize the benefits of establishing strong partnerships with their customers in the increasingly competitive atherectomy systems market.

Distributor Sales:

Distributor sales play a crucial role in the atherectomy systems market, as many manufacturers rely on established distribution networks to reach a broader audience. Distributors typically have extensive relationships within the healthcare sector, allowing them to effectively market and sell atherectomy systems to hospitals, surgical centers, and specialty clinics. By leveraging the expertise of distributors, manufacturers can ensure their products are readily available in diverse markets, including emerging economies where access to advanced medical technologies is still developing. The collaboration between manufacturers and distributors is essential for driving market growth and expanding the reach of atherectomy systems globally.

By Region

The North American atherectomy systems market is the largest globally, accounting for approximately 45% of total market revenue in 2025. This dominance can be attributed to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and significant investments in medical technology. The growing adoption of minimally invasive procedures fueled by favorable reimbursement policies further propels market growth in the region. With a CAGR of 6.5% expected during the forecast period, North America is likely to maintain its leading position, driven by continuous innovation and the increasing number of cardiovascular interventions.

Europe holds the second-largest share of the atherectomy systems market, representing about 30% of the global market. The region benefits from a well-established healthcare system, increasing awareness of cardiovascular health, and a growing aging population. The increasing prevalence of lifestyle-related diseases, such as obesity and diabetes, is also contributing to the rising demand for effective cardiovascular interventions. Asia Pacific is emerging as a significant market for atherectomy systems, projected to grow at a CAGR of 7.0% due to improving healthcare infrastructure, rising disposable incomes, and increasing access to advanced medical technologies. As these regions experience rapid growth, the global atherectomy systems market is expected to flourish.

Opportunities

The atherectomy systems market is poised for substantial growth, offering numerous opportunities for stakeholders involved in cardiovascular health. One of the most significant opportunities lies in the development of innovative atherectomy devices that integrate advanced technologies such as robotics and artificial intelligence. These innovations can improve procedural accuracy and efficiency, catering to the increasing demand for minimally invasive cardiac interventions. Moreover, the expansion of telemedicine and remote patient monitoring can enhance patient access to healthcare services, thereby creating additional demand for atherectomy procedures. As more healthcare providers adopt these advancements, the atherectomy systems market will witness new avenues for growth and development, ultimately improving patient outcomes and satisfaction.

Another opportunity for growth in the atherectomy systems market is the increasing focus on preventive healthcare measures aimed at reducing the prevalence of cardiovascular diseases. With governments and healthcare organizations emphasizing the importance of early detection and intervention, there is a significant opportunity for atherectomy systems to play a critical role in managing cardiovascular health. Additionally, the rising awareness of heart health among consumers will fuel demand for diagnostic and interventional technologies. Stakeholders can capitalize on this trend by developing educational programs and partnerships with healthcare providers to promote the benefits of atherectomy as a viable treatment option for patients at risk of cardiovascular complications.

Threats

One of the primary threats to the atherectomy systems market stems from the competitive landscape, as numerous manufacturers are vying for market share in this lucrative sector. Intense competition may lead to price erosion, potentially impacting the profitability of companies operating in this space. Furthermore, the rapid introduction of new technologies and treatment modalities could disrupt the market, forcing existing players to adapt quickly or risk obsolescence. Regulatory challenges and the need for rigorous clinical validation of new devices also pose potential barriers to market entry for new players, complicating the competitive environment within the atherectomy systems market.

Besides competition, the atherectomy systems market is also subject to external factors that may hinder growth. Economic fluctuations and uncertainties can impact healthcare spending, leading to reduced investments in advanced medical technologies. Additionally, variations in reimbursement policies across different regions can create disparities in market accessibility, limiting the adoption of atherectomy systems in certain areas. Concerns regarding patient safety and the potential for complications arising from atherectomy procedures may also deter healthcare providers from using these devices, which could further challenge market growth.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic Plc
• Abbott Laboratories
• Cordis Corporation
• AngioDynamics Inc.
• Avinger Inc.
• Philips Healthcare
• Terumo Corporation
• Johnson & Johnson
• BD (Becton, Dickinson and Company)
• Cardiovascular Systems Inc.
• Spectranetics Corporation
• Medtronic's Mazor Robotics, Inc.
• Asahi Intecc Co., Ltd.
• Intuitive Surgical Inc.

The competitive landscape of the atherectomy systems market is characterized by the presence of several key players who are actively engaged in the development and commercialization of advanced devices. Companies are increasingly focused on research and development to create innovative atherectomy technologies that cater to the evolving needs of healthcare providers and patients. Collaborations and partnerships between manufacturers, distributors, and healthcare facilities are common strategies employed to enhance market penetration and expand geographic reach. Moreover, companies are investing in marketing and educational initiatives to raise awareness about atherectomy procedures and their benefits, fostering growth in the overall market.

Boston Scientific Corporation is one of the leading players in the atherectomy systems market, offering a diverse range of innovative products for cardiovascular interventions. The company is renowned for its commitment to research and development, which has led to the introduction of advanced atherectomy technologies that are widely used in clinical practice. Medtronic Plc, another major player, has a robust portfolio of atherectomy systems designed for various applications, supported by a strong global distribution network. Their focus on patient-centric solutions and technological advancements positions them favorably within the market. Abbott Laboratories also stands out, as it has made significant strides in providing effective atherectomy solutions, driven by its commitment to improving patient outcomes.

Emerging companies like Avinger Inc. and Cardiovascular Systems Inc. are making notable contributions to the atherectomy systems market with their innovative technologies. Avinger's focus on developing image-guided atherectomy systems has garnered attention for its ability to enhance procedural accuracy and safety. Cardiovascular Systems Inc., known for its groundbreaking orbital atherectomy technology, has gained a strong foothold in the market due to its effective solutions for treating complex arterial diseases. These companies demonstrate the dynamic nature of the atherectomy systems market, where both established players and innovative newcomers are shaping the future of cardiovascular interventions.